{"id":"W4408042402","doi":"10.1080/14796694.2025.2459548","title":"CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2– early breast cancer","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Endocrine system; Metastatic breast cancer; Cancer; Gynecology; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009913598,0.0005120931,0.00205247,0.0004230315,0.0001200375,0.00002792011,0.0002733294,0.0003817522,0.001441498],"category_scores_gemma":[0.0001668454,0.0004160871,0.0002986864,0.0007556111,0.0002560235,0.0001588506,0.00006106567,0.0008548122,0.00002412378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001775017,"about_ca_system_score_gemma":0.002091961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00303327,"about_ca_topic_score_gemma":0.007771135,"domain_scores_codex":[0.9963666,0.0006333042,0.001045823,0.0007424962,0.000385754,0.0008260715],"domain_scores_gemma":[0.9977984,0.0006501902,0.0003586788,0.0006527312,0.0003083501,0.0002316369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2491198,0.0008693179,0.001756256,0.00008435282,0.001049283,0.0004832992,0.001159384,0.00002423236,0.01500218,0.001226447,0.00643661,0.7227889],"study_design_scores_gemma":[0.1679756,0.002468431,0.01837395,0.0002389018,0.0003031612,0.0002319275,0.0008030524,0.00000895329,0.001348275,0.000162411,0.8076933,0.0003920927],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9241165,0.0174396,0.001000352,0.03637332,0.01073885,0.002948219,0.001184311,0.0003054397,0.005893382],"genre_scores_gemma":[0.9710181,0.008103689,0.002620191,0.003811341,0.006975313,0.001126313,0.0002273054,0.0001452662,0.005972489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8012567,"threshold_uncertainty_score":0.9998291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04278605245297019,"score_gpt":0.4233400671943058,"score_spread":0.3805540147413356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}